The report on Premature Ejaculation Treatment Market by Infinium Global Research analyzes over the period of 2016 to 2022. This report also provides detailed qualitative and quantitative analyses of the market dynamics, market size and future trends in Global Premature Ejaculation Treatment Market. It will help a lot of decision makers to develop strategies and find new opportunities in the Global Premature Ejaculation Treatment Market.
The global market for premature ejaculation treatment was valued at around USD 1.2 billion in 2015 and is expected to reach USD 2.6 billion by 2022, growing at a CAGR of around 11.6% during the forecast period of 2016 to 2022. Premature ejaculation is uncontrolled ejaculation either before or shortly after sexual penetration. It happens with minimal sexual stimulation and before the person wishes. It may result in unsatisfactory sex for both partners. This can increase the anxiety that may add to the problem. It is one of the most common forms of male sexual dysfunction. It has probably affected every man at some point in his life.
Erectile Ddysfunction (ED) and Premature Eejaculation (PE) are the two most prevalent male sexual dysfunctions. The Global Study of Sexual Attitudes and Behaviors and other sources suggests a global prevalence of PE of approximately 20-30% across all age groups. Chances of sexual dysfunction increases with age, physical inactivity, smoking, diabetes, stress and prostate concerns.
Get a Sample Report @ https://www.infiniumglobalresearch.com/Reports/MakeSampleRequest/285
Worldwide approximately 100 million men are estimated to suffer from male sexual dysfunction. Rise in base of population with sexual disorders, changing lifestyle habits such as smoking, and drinking alcohol and increasing stress levels in the men due to the work life are some of the driving factors of this market. In addition, large number of drugs under pipeline for FDA approval and introduction of novel techniques are further expected to boost the market growth in the coming years.
Companies profiled:
• Janssen Pharmaceutica N. V. (a pharmaceutical company of Johnson and Johnson)
• Plethora Solutions Holdings PLC
• Akorn Pharmaceuticals
• Absorption Pharmaceuticals
• Allergan
• Innovus Pharmaceuticals
• GlaxoSmithKline
• Pfizer
Make an Enquiry @ https://www.infiniumglobalresearch.com/Reports/MakeEnquiryRequest/285
Key topics covered:
1. Scope of the report
2 Executive summaries
3 Qualitative analysis
4 Global premature ejaculation markets, by type, 2016 - 2022
5 Global premature ejaculation markets, by geography, 2016 - 2022
6 Company profiles
Click to View Complete Report @ https://www.infiniumglobalresearch.com/healthcare_medical_devices/global_premature_ejaculation_treatment_market